Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
The localization of the alpha3 subunit GABA receptor (GABRA3) gene in Xq28, a region of interest for BPAD suggests that GABRA3 may be a relevant candidate gene.
|
11602034 |
2001 |
Bipolar Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Recently, an association between a CA-repeat in the GABRA 3 gene and bipolar disorder had been reported.
|
15048654 |
2004 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Moreover, the localization of the alpha3 subunit GABA receptor GABRA3 gene on the Xq28, a region of interest in certain forms of bipolar illness, suggests that GABRA3 may be a candidate gene in BPAD.
|
11840313 |
2002 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Lack of association between manic-depressive illness and a highly polymorphic marker from GABRA3 gene.
|
8546157 |
1995 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
X-linked manic depression and other psychiatric disorders have been mapped to this region, and thus GABRA3 is a potential candidate gene for these disorders.
|
2574000 |
1989 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Recently, an association between a CA-repeat in the GABRA 3 gene and bipolar disorder had been reported.
|
15048654 |
2004 |
Bipolar Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Lack of association between manic-depressive illness and a highly polymorphic marker from GABRA3 gene.
|
8546157 |
1995 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
BEFREE |
The localization of the alpha3 subunit GABA receptor (GABRA3) gene in Xq28, a region of interest for BPAD suggests that GABRA3 may be a relevant candidate gene.
|
11602034 |
2001 |
Autistic Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
GABA(A) receptor downregulation in brains of subjects with autism.
|
18821008 |
2009 |
Mental Depression
|
0.300 |
Biomarker
|
disease |
PSYGENET |
This work suggests that GABRA3 regulates a behavioral endophenotype of depression and establishes this gene as a viable new target for the study and treatment of human depression.
|
20512339 |
2010 |
Depressive disorder
|
0.300 |
Biomarker
|
disease |
PSYGENET |
This work suggests that GABRA3 regulates a behavioral endophenotype of depression and establishes this gene as a viable new target for the study and treatment of human depression.
|
20512339 |
2010 |
Thyrotoxic periodic paralysis
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
Association of genetic variants in GABRA3 gene and thyrotoxic hypokalaemic periodic paralysis in Thai population.
|
17970773 |
2008 |
Graves Disease
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Obesity
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Quadriplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ventricular Fibrillation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Thyrotoxicosis with toxic single thyroid nodule
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Toxic multinodular goiter
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Second degree atrioventricular block
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Periodic hypokalemic paresis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Carcinoma of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, GABRA3 protein expression was significantly higher in the lower grade of lung cancer.
|
19048400 |
2009 |
Carcinoma of lung
|
0.030 |
Biomarker
|
disease |
BEFREE |
Here, we report identification of a novel cancer-germline transcript (CT-GABRA3) displaying DNA hypomethylation-dependent activation in various tumors, including melanoma and lung carcinoma.
|
25089631 |
2014 |
Carcinoma of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
The GABAA receptor subunit GABRA3 is reportedly upregulated in lung cancer.
|
27081042 |
2016 |
Malignant neoplasm of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The GABAA receptor subunit GABRA3 is reportedly upregulated in lung cancer.
|
27081042 |
2016 |
Malignant neoplasm of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, GABRA3 protein expression was significantly higher in the lower grade of lung cancer.
|
19048400 |
2009 |